Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/14/24 18:02 | 6/14/24 | NKTR | Health | Drug | Pharmaceutical Preparations | Chess Robert | CA | D | 1 | S | -23 | 1.20 | 0 | -20 | 262 | D | ||||||||||||||||
5/20/24 21:14 | 5/17/24 | NKTR | Health | Drug | Pharmaceutical Preparations | Robin Howard W | CA | DO | P,CEO | 1 | S | -29 | 1.75 | 0 | -17 | 864 | D | |||||||||||||||
5/20/24 21:13 | 5/17/24 | NKTR | Health | Drug | Pharmaceutical Preparations | Zalevsky Jonathan | CA | O | Chief R, | 1 | S | -13 | 1.75 | 0 | -7 | 258 | D | |||||||||||||||
5/20/24 21:12 | 5/17/24 | NKTR | Health | Drug | Pharmaceutical Preparations | Wilson Mark Andrew | CA | O | GC | 1 | S | -11 | 1.75 | 0 | -6 | 230 | D | |||||||||||||||
5/13/24 16:36 | 5/10/24 | NKTR | Health | Drug | Pharmaceutical Preparations | Deep Track Capital, LP | CT | T | 1 | S | -100 | 1.78 | 0 | -56 | 0 | 18,344 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |